The pharmaceutical giant had been in talks to buy the cancer drug developer in a transaction that could have valued ...

AI and genetics are creating a ‘seismic shift’ in the pharmaceutical business, experts on Asian Financial Forum panel say.

Jan 25 (Reuters) - Merck is no longer in discussions to buy cancer drug developer Revolution Medicines, the Wall Street ...

Investors are apparently taking bets on when Revolution will be acquired. A handful of pharmas could be interested as Merck ...

Corcept’s overall survival data “look competitive” with AbbVie’s Elahere and Merck’s blockbuster Keytruda, Truist Securities ...

Lingering doubts about Merck’s experimental heart pill pretty much vanished Sunday, when the drugmaker showed it cut levels of harmful LDL cholesterol as effectively as today’s injectable drugs. The ...

The FDA said Friday that Merck's anti-COVID-19 pill is effective in treating the virus but said that regulators will meet next week to investigate whether the pill is safe for people who are pregnant ...

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

The drugmaker had recently been in discussions to acquire RevMed in a deal that could have valued the cancer-drug biotech at ...